clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT01161004 |
P6099 | clinical trial phase | phase IV clinical trial | Q42825046 |
P17 | country | France | Q142 |
P582 | end time | 2011-08-01 | |
P2899 | minimum age | 18 | |
P1132 | number of participants | 50 | |
P6153 | research site | hôpital Foch | Q3145155 |
P1813 | short name | Sugarecovery | |
P580 | start time | 2010-09-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Pilot Study of EEG Signs of Awakening Secondary to Injection of Sugammadex: Evaluation by Recording Bispectral Index and NeuroSENSE (Prospective, Double-blind Study) |
Search more.